BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18622525)

  • 1. National study of asthma quality of life--application of the Asthma Quality of Life Questionnaire (AQLQ-M) by Marks in the Portuguese population.
    Ferreira J; Silveira P; Marques JA
    Rev Port Pneumol; 2008; 14(4):459-86. PubMed ID: 18622525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Portuguese version of the Asthma Quality of Life Questionnaire [AQLQ-M] by Marks.
    Ferreira J; Silveira P; Figueiredo MM; Andrade C; João F; Marques JA
    Rev Port Pneumol; 2005; 11(4):351-66. PubMed ID: 16279011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of the Asthma Quality of Life Questionnaire--marks in a sample of adult asthmatic patients in the United States.
    Gupchup GV; Wolfgang AP; Thomas J
    Clin Ther; 1997; 19(5):1116-25. PubMed ID: 9385498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma control in the Portuguese National Asthma Survey.
    Sá-Sousa A; Amaral R; Morais-Almeida M; Araújo L; Azevedo LF; Bugalho-Almeida A; Bousquet J; Fonseca JA
    Rev Port Pneumol (2006); 2015; 21(4):209-13. PubMed ID: 25926249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of two common asthma-specific quality of life questionnaires: Juniper mini asthma quality of life questionnaire and Sydney asthma quality of life questionnaire.
    Apfelbacher CJ; Jones C; Hankins M; Smith H
    Health Qual Life Outcomes; 2012 Aug; 10():97. PubMed ID: 22906054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting.
    Ehrs PO; Nokela M; Ställberg B; Hjemdahl P; Wikström Jonsson E
    Chest; 2006 Apr; 129(4):925-32. PubMed ID: 16608940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a standardized version of the Asthma Quality of Life Questionnaire.
    Juniper EF; Buist AS; Cox FM; Ferrie PJ; King DR
    Chest; 1999 May; 115(5):1265-70. PubMed ID: 10334138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and reliability of "Asthma Quality of Life Questionnaire" in a sample of Turkish adult asthmatic patients.
    Ozgen Alpaydin A; Yorgancioğlu A; Yilmaz O; Bora M; Göktalay T; Celik P; Yüksel H
    Tuberk Toraks; 2011; 59(4):321-7. PubMed ID: 22233301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in asthmatic outpatients.
    Almada Lobo F; Almada-Lobo B
    J Asthma; 2008; 45(1):27-32. PubMed ID: 18259992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a community-specific health-related quality of life (HRQOL) questionnaire for asthma: the Asthma-Specific Quality of Life Questionnaire for Native American Adults (AQLQ-NAA).
    Gupchup GV; Hubbard JH; Teel MA; Singhal PK; Tonrey L; Riley K; Rupp MT; Coultas DB
    J Asthma; 2001 Apr; 38(2):169-78. PubMed ID: 11321688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
    Rubin AS; Souza-Machado A; Andradre-Lima M; Ferreira F; Honda A; Matozo TM;
    J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the asthma quality of life questionnaire (AQLQ-UK English version) in Indian asthmatic subjects.
    Chhabra SK; Kaushik S
    Indian J Chest Dis Allied Sci; 2005; 47(3):167-73. PubMed ID: 16022143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma.
    Pereira Barbosa M; Bugalho de Almeida A; Pereira C; Chen CW; Georgiou P; Peachey G;
    Rev Port Pneumol (2006); 2015; 21(3):151-6. PubMed ID: 25926246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the responsiveness of the Asthma Quality of Life Questionnaire with pharmaceutical care.
    Kheir NM; Emmerton L; Shaw JP
    Pharm World Sci; 2008 Aug; 30(4):322-8. PubMed ID: 18008177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma control test and asthma quality of life questionnaire association in adults.
    Alpaydin AO; Bora M; Yorgancioglu A; Coskun AS; Celik P
    Iran J Allergy Asthma Immunol; 2012 Dec; 11(4):301-7. PubMed ID: 23264406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.
    Brusselle G; Michils A; Louis R; Dupont L; Van de Maele B; Delobbe A; Pilette C; Lee CS; Gurdain S; Vancayzeele S; Lecomte P; Hermans C; MacDonald K; Song M; Abraham I
    Respir Med; 2009 Nov; 103(11):1633-42. PubMed ID: 19619998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in quality of life with omalizumab in patients with severe allergic asthma.
    Chipps B; Buhl R; Beeh KM; Fox H; Thomas K; Reisner C
    Curr Med Res Opin; 2006 Nov; 22(11):2201-8. PubMed ID: 17076981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the Asthma Quality of Life Questionnaire (AQLQ): Serbian translation.
    Tomic Spirić V; Bogić M; Janković S; Maksimović N; Matovic Miljanović S; Peric Popadić A; Rasković S; Milić N
    Croat Med J; 2004 Apr; 45(2):188-94. PubMed ID: 15103757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent asthma.
    Banov C; Howland WC; Lumry WR; Parasuraman B; Uryniak T; Liljas B
    Allergy Asthma Proc; 2003; 24(2):129-36. PubMed ID: 12776447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of asthma control and quality of life in severe allergic asthmatics under treatment with anti-IgE, omalizumab].
    Pacheco-Galván A; Hinojosa-Macías M; Hurtado-Barbudo B; González-Cervera J; Sueiro-Bendito A
    Med Clin (Barc); 2009 Oct; 133(12):460-3. PubMed ID: 19775710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.